SCHEMBL6169656

SCHEMBL6169656

COC(=O)C(O)c1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 16/20 0.59
CA1 P00915 4/20 0.59
CA2 P00918 4/20 0.59
MT-CO2 P00403 3/20 0.59
CA12 O43570 3/20 0.59
CA9 Q16790 3/20 0.59
PTGS1 P23219 3/20 0.59
CA4 P22748 2/20 0.59
CA7 P43166 2/20 0.59
LMNA P02545 1/20 0.59
CA3 P07451 1/20 0.59
ADRB2 P07550 1/20 0.59
ADRB1 P08588 1/20 0.59
CYP3A4 P08684 1/20 0.59
ADORA3 P0DMS8 1/20 0.59
CHRM1 P11229 1/20 0.59
ADRA2B P18089 1/20 0.59
CA6 P23280 1/20 0.59
SLC6A2 P23975 1/20 0.59
PDE4A P27815 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8474584 0.89 PTGS2 (0.59) PTGS2CA1CA2MT-CO2CA12
SCHEMBL8474588 0.88 PTGS2 (0.58) PTGS2CA1CA2MT-CO2CA12
SCHEMBL5983421 0.85 PTGS2 (0.68) PTGS2CA1CA2MT-CO2CA12
SCHEMBL6169647 0.83 PTGS2 (0.60) PTGS2CA1CA2MT-CO2CA12
SCHEMBL4884123 0.82 PTGS2 (0.64) PTGS2CA1CA2MT-CO2CA12
SCHEMBL4891512 0.81 PTGS2 (0.70) PTGS2CA1CA2MT-CO2CA12
SCHEMBL8477236 0.81 PTGS2 (0.60) PTGS2CA1CA2MT-CO2CA12
SCHEMBL6169802 0.80 PTGS2 (0.61) PTGS2CA1CA2MT-CO2CA12
SCHEMBL4809281 0.79 PTGS2 (0.70) PTGS2CA1CA2MT-CO2CA12
SCHEMBL8475026 0.79 PTGS2 (0.60) PTGS2CA1CA2MT-CO2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1528059-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle LLC (US) 2005-05-04 EP disclosed
EP-0809636-B1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-09-04 EP disclosed
EP-1223167-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle & Co. (US) 2002-07-17 EP disclosed